Delcath Systems

Patent cliffs & loss of exclusivity

A pharmaceutical and medical device company developing percutaneous perfusion technologies for the adninistration chemotherapeutic agents

Company

AngelList URLhttps://angel.co/delcath-systems
Legal NameDelcath Systems, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/delcath-systems
Email format{f}{last}
Full Address1633 Broadway, 22nd Floor, Suite C, New York, NY 10019, US
Legal Entity Identifier549300NVPLITUM6URT02
LinkedIn URLhttps://www.linkedin.com/company/delcath-systems-inc/

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. HEPZATOMELPHALAN HYDROCHLORIDESmall mol.Sep 2034

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Delcath Systems — patent cliffs & loss of exclusivity | CliffBio